Christopher Hepler is currently the Site Head at Solvias North America, where they lead operations in the biologics sector. With over 13 years of experience in the biopharmaceutical industry, Hepler has held leadership roles at Catalent Pharma Solutions, including Group Leader and Director, and has driven substantial financial success through strategic management. Hepler’s expertise encompasses global product development, operations management, and biologics mergers and acquisitions, with a proven track record in project management and regulatory compliance. They were also recognized as a thought leader and mentor within the Next Generation of Global Leaders program. Previously, Hepler worked with Eli Lilly and Company and was instrumental in developing biological assays and leading critical projects at several notable organizations.
This person is not in the org chart
This person is not in any teams
This person is not in any offices